Clinical Trials Browser

Phase 1/2 × INDUSTRY × relmapirazin × Clear all

NCT04109482 2024-07-22

Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.

Phase 1/2 Terminated

Blastic Plasmacytoid Dendritic Cell Neoplasm